Emanuele Crupi

9PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersMolecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.

|Aug 16, 2025
HER2 and urothelial carcinoma: current understanding and future directions.

Daniele Raggi, Emanuele Crupi, Filippo Pederzoli

|Jun 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.

Valentina Tateo, Joep J de Jong, Antonio Cigliola

|Mar 04, 2025
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis.

Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi

|Dec 24, 2024
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI.

Giorgio Brembilla, Giuseppe Basile, Michele Cosenza

Pageof 2

Frequent Collaborators

5 joint publications

Andrea Necchi

4 joint publications

Antonio Cigliola

4 joint publications

Chiara Mercinelli

4 joint publications

Daniele Raggi